Yahoo
BURLINGTON, Mass. AP) — Minerva Neurosciences Inc. NERV) on Tuesday reported a loss of $4.3 million in its fourth quarter.
Yahoo
BURLINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates and financial results for the fourth quarter and year ended December 31, 2024. Corporate Update As previously disclosed in the first quarter of 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to our New
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 35.03% | $4.85B | 0.35% |
IBB | 33.79% | $5.17B | 0.45% |
BBH | 31.12% | $326.56M | 0.35% |
PBE | 28.64% | $215.67M | 0.58% |
FBT | 28.55% | $1.00B | 0.56% |
PLDR | 28.11% | $684.49M | 0.6% |
GNOM | 27.89% | $39.83M | 0.5% |
PINK | 27.36% | $129.38M | 0.5% |
FTSL | 26.74% | $2.38B | 0.87% |
CLOU | 26.58% | $361.77M | 0.68% |
ESPO | 26.27% | $342.66M | 0.56% |
ARKG | 25.92% | $914.43M | 0.75% |
IWMY | 25.80% | $111.70M | 1.02% |
VHT | 25.71% | $14.85B | 0.09% |
PRNT | 25.36% | $79.40M | 0.66% |
FHLC | 25.27% | $2.39B | 0.084% |
PTH | 24.95% | $98.02M | 0.6% |
HERO | 24.57% | $138.13M | 0.5% |
XPH | 24.52% | $137.67M | 0.35% |
IXJ | 24.36% | $3.75B | 0.41% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -21.17% | $116.60M | 0.85% |
TAIL | -20.73% | $140.64M | 0.59% |
TPMN | -17.50% | $31.59M | 0.65% |
ULST | -12.34% | $632.05M | 0.2% |
GBIL | -11.88% | $6.16B | 0.12% |
BTAL | -11.53% | $361.71M | 1.43% |
TBIL | -9.86% | $5.77B | 0.15% |
DBE | -8.16% | $46.44M | 0.77% |
UNG | -7.48% | $335.18M | 1.06% |
SPSK | -7.14% | $307.42M | 0.5% |
CCOR | -6.88% | $59.80M | 1.18% |
UUP | -6.79% | $279.52M | 0.77% |
IBTP | -6.50% | $129.80M | 0.07% |
XONE | -6.04% | $608.48M | 0.03% |
DBO | -6.04% | $178.84M | 0.77% |
USDU | -5.99% | $173.33M | 0.5% |
XLU | -5.12% | $18.65B | 0.09% |
MINO | -5.11% | $318.17M | 0.39% |
GOVT | -4.91% | $27.19B | 0.05% |
VPU | -4.78% | $6.86B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TBLL | -0.05% | $2.38B | 0.08% |
FIXD | 0.07% | $3.55B | 0.65% |
FMHI | 0.11% | $762.95M | 0.7% |
IBTL | -0.14% | $368.52M | 0.07% |
LDUR | -0.15% | $850.25M | 0.5% |
IBTG | 0.17% | $1.89B | 0.07% |
XHLF | 0.17% | $1.46B | 0.03% |
PULS | 0.22% | $11.19B | 0.15% |
SHV | 0.27% | $20.91B | 0.15% |
NUAG | -0.27% | $57.73M | 0.21% |
CANE | 0.29% | $10.45M | 0.29% |
IBTO | -0.31% | $338.77M | 0.07% |
VTEB | -0.34% | $35.63B | 0.03% |
COMT | -0.38% | $596.02M | 0.48% |
GCOR | 0.40% | $538.61M | 0.08% |
GSG | 0.41% | $896.58M | 0.75% |
EDV | -0.43% | $3.41B | 0.05% |
MMIN | -0.46% | $471.84M | 0.3% |
FXU | 0.52% | $1.63B | 0.64% |
VGIT | -0.53% | $31.42B | 0.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 37.27% | $2.02B | -30.90% | 0.00% |
GPCR | 37.15% | $1.44B | -30.13% | 0.00% |
CVAC | 34.17% | $871.35M | +13.82% | 0.00% |
ANAB | 31.55% | $601.42M | -18.15% | 0.00% |
BNTX | 30.88% | $23.51B | +5.76% | 0.00% |
DHR | 30.73% | $140.56B | -26.47% | 0.57% |
IDYA | 29.65% | $1.58B | -55.16% | 0.00% |
ROIV | 29.30% | $7.73B | -4.66% | 0.00% |
CLFD | 29.26% | $539.82M | +7.76% | 0.00% |
GPRO | 29.18% | $95.32M | -61.22% | 0.00% |
BIO | 28.81% | $6.77B | -14.81% | 0.00% |
RCKT | 28.63% | $694.91M | -71.75% | 0.00% |
NNOX | 28.52% | $349.42M | -43.79% | 0.00% |
CMBM | 28.21% | $13.70M | -86.49% | 0.00% |
TVTX | 28.16% | $1.51B | +175.69% | 0.00% |
SDGR | 27.98% | $1.73B | +4.25% | 0.00% |
IPGP | 27.98% | $2.79B | -26.02% | 0.00% |
AKRO | 27.92% | $3.04B | +89.37% | 0.00% |
VYGR | 27.92% | $189.80M | -59.41% | 0.00% |
BMRN | 27.62% | $11.39B | -22.89% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PPC | -11.64% | $11.56B | +44.37% | 0.00% |
STG | -11.41% | $28.09M | -38.64% | 0.00% |
SO | -10.57% | $98.34B | +12.99% | 3.22% |
LFVN | -9.48% | $165.91M | +83.57% | 1.20% |
NEE | -9.26% | $152.05B | -2.65% | 2.82% |
TIMB | -7.98% | $8.38B | +6.18% | 2.99% |
VSA | -7.72% | $6.80M | -46.67% | 0.00% |
KLG | -7.60% | $1.54B | -14.29% | 3.58% |
BE | -7.39% | $4.47B | +48.84% | 0.00% |
AEP | -7.12% | $55.44B | +12.09% | 3.53% |
LNT | -7.03% | $16.21B | +21.84% | 3.10% |
LMT | -6.80% | $110.84B | +1.28% | 2.73% |
DUK | -6.73% | $90.93B | +12.86% | 3.55% |
TRVG | -6.30% | $106.63M | +114.71% | 0.00% |
MSIF | -6.20% | $753.44M | +35.28% | 6.67% |
UGP | -6.08% | $3.40B | -34.30% | 3.97% |
CME | -6.03% | $100.16B | +31.56% | 3.79% |
TECX | -5.89% | $437.12M | +40.35% | 0.00% |
FIZZ | -5.76% | $4.21B | +3.21% | 0.00% |
DKL | -5.63% | $2.21B | +4.87% | 10.68% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EBR | -0.06% | $14.71B | +2.47% | 0.00% |
SBAC | -0.06% | $25.31B | +18.70% | 1.72% |
HE | 0.08% | $1.84B | -4.64% | 0.00% |
UGI | 0.08% | $7.70B | +46.41% | 4.14% |
PARAA | 0.09% | $15.31B | +8.19% | 0.89% |
PRDO | 0.09% | $2.06B | +33.85% | 1.60% |
HIHO | 0.10% | $8.36M | -10.75% | 3.76% |
INNV | 0.11% | $565.70M | -2.78% | 0.00% |
NUS | -0.11% | $368.13M | -44.73% | 3.20% |
AMT | -0.14% | $100.71B | +12.19% | 3.05% |
NVT | -0.15% | $10.96B | -18.47% | 1.17% |
BEKE | -0.17% | $21.83B | 0.00% | 1.93% |
CCI | -0.18% | $44.84B | +2.35% | 6.08% |
CTRA | -0.20% | $18.70B | -13.82% | 3.51% |
SANA | -0.20% | $378.93M | -80.53% | 0.00% |
PBT | 0.21% | $510.83M | -18.57% | 3.83% |
EVH | -0.21% | $1.01B | -62.36% | 0.00% |
PARR | -0.22% | $1.05B | -28.85% | 0.00% |
STRL | 0.25% | $5.66B | +41.75% | 0.00% |
LQDT | -0.25% | $771.78M | +25.04% | 0.00% |
Current Value
$1.441 Year Return
Current Value
$1.441 Year Return